Renal effect of SB 7505: a double-blind study
- PMID: 7011819
- DOI: 10.1007/BF00561945
Renal effect of SB 7505: a double-blind study
Abstract
Two groups of 20 patients with no evidence of cardiovascular, hepatic, renal or gastrointestinal failure were treated orally for five days with placebo or SB 7505 100 mg/day. No change was observed in heart rate or blood pressure. Urine output, the excretion of Na, K and Cl, and creatinine clearance were significantly increased.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
